KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Gains from Investment Securities (2016 - 2025)

Teva Pharmaceutical Industries' Gains from Investment Securities history spans 17 years, with the latest figure at -$2.0 million for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities changed N/A year-over-year to -$2.0 million, compared with a TTM value of -$7.0 million through Dec 2025, down 250.0%, and an annual FY2025 reading of -$5.0 million, down 150.0% over the prior year.
  • Gains from Investment Securities for Q3 2025 was -$2.0 million at Teva Pharmaceutical Industries, up from -$3.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $4.0 million in Q4 2022, with the low at -$3.0 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $0.0, with a median of $1.0 million recorded in 2022.
  • Biggest YoY gain for Gains from Investment Securities was 300.0% in 2023; the steepest drop was 125.0% in 2023.
  • Tracing TEVA's Gains from Investment Securities over 5 years: stood at $2.0 million in 2021, then skyrocketed by 100.0% to $4.0 million in 2022, then tumbled by 125.0% to -$1.0 million in 2023, then plummeted by 100.0% to -$2.0 million in 2024, then changed by 0.0% to -$2.0 million in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Gains from Investment Securities are -$2.0 million (Q3 2025), -$3.0 million (Q2 2025), and -$2.0 million (Q4 2024).